Public Awareness and Advanced Technology to Boost Cord Blood Banking Services Market to USD 27.2 Billion by 2020

Public Awareness and Advanced Technology to Boost Cord Blood Banking Services Market to USD 27.2 Billion by 2020

According to a new market research report published by iHealthcareAnalyst, Inc., Cord Blood Banking Services Market – Global Therapeutic Applications Analysis and Forecast 2016-2020, the global cord blood banking services market is estimated to reach USD 27.2 Billion in 2020, expanding at a CAGR of 5.3% from 2016 to 2020.

Visit the Cord Blood Banking Services Market – Global Therapeutic Applications Analysis and Forecast 2016-2020 report at https://www.ihealthcareanalyst.com/report/cord-blood-banking-services-market/

Cord blood banking facilities stores umbilical cord blood for future use in response to the potential for cord blood in treating diseases of the blood and immune systems. Both private and public cord blood banks have developed. Cord blood stem cells are blood cell progenitors which can form red blood cells, white blood cells, and platelets and are currently used to treat blood and immune system related genetic diseases, cancers, and blood disorders. The global cord blood banking services market report estimates the market size (Revenue USD million – 2013 to 2020) and composition of this market based on type of therapy (standard therapy for leukemia, lymphoma, blood-related disorders and metabolic diseases; and stem cell therapy for autoimmune and cardiovascular disorders, diabetes, etc.), and by ownership type (public and private) and forecasts growth trends (CAGR% – 2016 to 2020). It also analyses the major companies operating in the global market.

The global cord blood banking services market is segmented as:

  1. Ownership Type
    • Private Banks
    • Public Banks
  1. Therapy Type
    • Standard Therapy
      • Blood Cell Proliferative Disorders
      • Leukemia
      • Lymphoma
      • Transplants for Inherited Diseases Affecting Immune System and Related Organs
      • Transplants for Inherited Metabolic Conditions
    • Stem Cells Therapy (Diabetes Mellitus, Cardiovascular, Auto-Immune Diseases, etc.)
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
  1. Company Profiles
    • China Cord Blood Corporation
    • Cord Blood America, Inc.
    • Cord Blood Registry Systems, Inc.
    • Cordlife Group Ltd.
    • Cryo-Cell International, Inc.
    • Cryo-Save Group AV
    • NeoStem, Inc.
    • ViaCord, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2016-10-14T06:19:51+00:00 Categories: Press Releases|